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SUlTlnlary 
The  lipooligosaccharide  (LOS)  expressed by gonococci  spontaneously varies its  structure  at 
high frequency, but the underlying genetic mechanism has not been described. We have previ- 
ously reported that the genes encoding the glycosyl transferases responsible for the biosynthesis 
of the variable o~ chain of the LOS of Neisseria gonorrhoeae are located in a locus containing five 
genes, lgtA,  lgtB,  IgtC,  IgtD, and lgtE.  Sequence analysis  showed that tgtA,  lgtC,  and IgtD con- 
tained poly-G tracts within the coding frames, leading to the hypothesis that shiftsin the num- 
ber of guanosine residues in the poly-G tracts might be responsible for the.high frequency vari- 
ation in structure of gonococcal LOS. We now provide experimental evidence confirming this 
hypothesis. 
T 
he  lipopolysaccharide  of  gonococci  (GC)  is  small 
compared with that of enteric bacteria, and is often re- 
ferred to  as lipooligosaccharide or LOS.  The structure  of 
the LOS of a few strains of GC has been published  (1-3) 
and is summarized in Fig.  1. Of particular note as the prin- 
cipal carbohydrate chain on heptose, which is known as the 
cx chain and is subject to phase variation at several points in 
its  structure.  Fig.  1 A  shows  the  most complete structure 
that  has  been  reported  for strain  F62  (1).  In  the  smallest 
naturally occurring variant, the c~ chain consists ofa lactosyl 
group (Gal[31-4Glc[~1-). This LOS has an apparent molec- 
ular weight of 3,600 and reacts with mAbs 2-1-L8 and 4C4 
as indicated in Fig. 1 (4, 5).  GC undergo a variation at high 
frequency  (10-2-10 -3 per generation)  between  the  3,600 
tool wt LOS and a form with an apparent molecular weight 
of 4,500 that reacts with mAb 3Fll.  The tetrasaccharide o~ 
chain may be further substituted with a GalNAc residue to 
form the pentasaccharide shown in Fig. 1 A. van Putten (6) 
has reported high frequency variation of the ability of LOS 
to react with mAb l-l-M, which is specific for the termi- 
nal  GalNAc.  An  alternative  substitution  of  the  lactosyl 
group  with  an  od-4-1inked  Gal  produces  the  structures 
shown  in  Fig.  1  B.  This  structure  has  been  reported  for 
strain  1291b  (3)  and  reacts  with  mAb  1-17-L1.  The  fact 
that  these  structures  are mimics of human  glycolipids has 
been noted previously (7).  The ca chain may be the pen- 
tasaccharide GalNAc[31-3Ga1131-4GlcNAc[31-3Ga1131-4Glc, 
which  is  identical  to  the  human  red  cell X 2 antigen  (8). 
When the terminal GalNAc is not added,  the tetrasaccha- 
ride is identical to lacto-N-neotetraose, the  core structure 
of the  blood  group  substances  (7).  The  Galc~l-4Gal~l- 
4Glc trisaccharide is found on globotriglycosyl ceramide or 
the pk blood group antigen (7).  Finally, the c~ chain can be 
limited to a disaccharide lactosyl unit and is then identical 
to lactosylceramide. 
Recently we have characterized a locus in Neisseria gonor- 
rhoeae strain F62 that is responsible for the synthesis of the 
chain of LOS. The locus contains five open reading frames 
coding  for glycosyl transferases,  and  by immunochemical 
and biochemical analysis  of deletion mutants, the function 
of the  genes was determined and is summarized in  Fig.  1 
(9).  Three  of the  glycosyl transferases  contained  tracts  of 
poly-G within the coding frame coding for rns  ofglycines 
in the predicted proteins. This suggested that the high fre- 
quency  antigenic  variation  of GC  LOS  could  be  due  to 
slipped  strand  mispairing  during  replication,  causing pre- 
mature  termination  of translation.  This  form of variation 
has been seen in the case of the pilC protein (10),  a G.C pi- 
lus  accessory protein  imparting  adhesiveness  to  epithelial 
cells (11).  The glycosyl transferases that might be subject to 
this  form  of variation  are  IgtA,  the  GlcNAc  transfer~tse; 
lgtD,  the  GalNAc transferase; and IgtC,  the Gal Xransferase 
responsible for the addition of o~Gall-4f3Gal. 
This report demonstrates that high frequency generic vari- 
ation of LOS str  cture is attributable to changes in the num- 
ber of G residues in the poiy-G tracts in genomic DNA. 
Materials and Methods 
Colony Immunoblots.  GC on GC agar (12) were grown over- 
night,  suspended and diluted in proteose peptone liquid medium 
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,'ol,000 small colonies. The agar cultures were overlaid with ni- 
trocellulose filters (Schleicher &  Schuell, Inc., Keene, NH), lifted 
off,  and  air-dried  for  60  rain.  The  plates  were  reincubated  at 
30~  in a candle jar. The filters were wetted, immersed individu- 
ally in  petri  dishes  in  3%  gelatin in  150  mM  NaCI  in  10  mM 
Tris-HC1,  pH  7.5,  with  0.02%  NAN3,  and  rocked  for 60  rain. 
Subsequently all reactions were  carried out in  1% gelatin in the 
same buffer with rocking. The filters were washed once for 10 rain 
and reacted for 60 min with a  t:2,000  dilution ofmAb  17-1-L1 
(L1).  They were washed four times and placed in a  1:2,000 dilu- 
tion of alkaline phosphatase-conjugated  anti-mouse immunoglo- 
bulin antiserum  (Cappel,  Organon  Teknika  Co.,  West  Chester, 
PA). The filters were washed four times for 10 rain each, washed 
for  1 min with 50 mM Tris base  containing 3  mM MgC12,  and 
then stained as previously described (13). 
Purification and Electrophoresis  of LOS.  LOS was prepared by a 
modification of the hot phenol extraction  method  and  analyzed 
electropboretically (9). 
PCR Reactions.  GC genomic DNA (usually 100 ng) was used 
as  a  template.  The  PCR. conditions  consisted of initial denatur- 
ation of DNA for 2  n'fin at 94~  followed by 25  cycles of 60~ 
for 60  s,  72~  for 30 s,  and 94~  for 30 s.  One additional cycle 
with  a  4-rain  extension  time  at  72~  was  performed.  The  re- 
agents used were part  of a Gene Amp kit  (Perkin  Ehner Corp., 
Branchburg,  NJ) with 0.5/.~1 of Taq polymerase per 100-/.~1 reac- 
tion and primers at 0.1  IxM-  The primers are described by their 
position  in  the  sequence  deposited in  Genbank  under  accession 
number U14554  (9).  To amplify an 893-bp  fragment containing 
the poly-G region of IgtA, a primer pair matching 309-328  and 
the reverse complement of 1182-1202  was used; the first primer 
was  biotinylated.  To  amplify a  467-bp  fragment  containing the 
poly-G region of lgtC, primers matching 2249-2275  and the re- 
verse complement of 2693-2716  were used; the first  primer was 
biotinylated. 
DNA Sequencing.  DNA sequencing was performed using the 
Sequenase  II  kit  (United  States  Biochemical  Corp.,  Cleveland. 
OH).  The PC1< products were purified by absorption to strepta- 
vidin-coated  magnetic  beads,  and  single-stranded  template  was 
eluted  with  NaOH  and  sequenced  (14).  Plasmid  was  purified 
by  the  spin-prep  method  (Qiagen  Inc.,  Chatsworth,  CA).  The 
poly-G  region  in  lgtA  was  sequenced  in  both  directions  using 
primers matching 607-623  and the reverse complement of 797- 
813.  Similarly, the region in IgtC was sequenced on both strands 
using primers matching 2410-2426  and the reverse complement 
of 2573-2589. 
Cloning of lgtA and lgtC Region.  Genomic DNA was prepared 
from  F62  A1  and variants  1-1,  2-1,  and  1-6.  12-1xg  aliquots  of 
DNA were digested with ClaI, and the digests were separated by 
gel  electrophoresis  on  0.8%  agarose  (SeaPlaque;  FMC  Corp., 
l<ocldand,  ME), the region containing DNA around  2.3-3.0  kb 
excised,  and  the  DNA  purified  using  Geneclean  1I  (BIO  101, 
Inc.,  La Jolla,  CA).  The  fragments  were  ligated  into  ClaI-cut 
pBluescript KS  +, transformed  into XL1-Blue MR.F'-competent 
cells, and  the  desired clone isolated by plating on  LB  agar con- 
taining 50  Ixg/ml carbenicillin and 200  txg/ml erythromycin and 
incubating at 30~  For variants A and C  of strain MS11, the ge- 
nomic DNA was digested with ClaI and PstI and,  after size frac- 
tionation  and  purification  as  above,  ligated  into  pBluescript  II 
SK-  cut with  the  same  restriction  enzymes.  The  desired clones 
were  identified  by  colony  hybridization  (15)  using  32p-labeled 
oligonucleotide matching the reverse complement of 2573-2589. 
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Figure 1.  Structures  of gonococcal  LOS.  (A) The complete structure 
that has been reported  for strain F62 (1) and MS11 variant C (2). (B) The 
alternative  LOS structure,  which has been observed  in strain 1291b (3) 
and in the mutant strain F62 A1 (9). The second structure differs from the 
first in that  it bears a terminal  ctl-4--linked  galactose instead of a [31-3- 
1inked N-acetyl glucosamine.  As indicated  in the figure,  this alternative 
LOS structure can be recognized by its reactivity with mAb 1%1-L 1. The 
reactivities of a number ofweU-characterized  mAbs are shown.  The LOS 
glycosyl transferase gene (lgtA, B, C, D, E) responsible for the addition of 
each of the residues are indicated. The underlined  lgt genes contain poly- 
G tracts in their coding frames. KDO, keto deoxyoctulosonic  acid; HEP, 
heptose. 
Results 
Changes in the poly-G tract of lgtC should affect the ad- 
dition  of the  terminal  Gal  in  the  LOS  structure  ~Ga11- 
4{3Ga11-413G1c1-R.  The o~-Gal transferase  encoded by IgtC 
appears  to compete poorly with the GlcNAc transferase  for 
substrate;  its activity is evident only if lgtA is silent  (9).  We 
therefore  used  mutant  F62  A1  with  a  deletion  in  lgtA, 
which produces  an LOS with the structure  shown in Fig.  1 
B  (9).  Colony  immunoblots  were  performed  with  mAb 
17-1-L1  and  briefly  stained  with  safranin  to  visualize  the 
colonies that  were not imnmnoreactive.  We  isolated three 
independent  colonies that  did not react with the antibody. 
LOS from these clones, designated as variants  1-1,  2-1,  and 
1-6,  was  prepared  and  compared  by  SDS-PAGE  (Fig.  2) 
with the F62 A1 parent and F62 A5 mutant known  to pro- 
duce a LOS with an o~ chain limited to a lactosyl group  (9). 
Figure 2.  Silver-stained  SDS- 
PAGE of LOS preparations.  F62 
wild type  (wt) gives rise to two 
principal  LOS bands, the lacto- 
N-neotetraose  structure with and 
without  the  terminal  GalNAc 
substitution.  F62  Al  expresses 
mainly Gakxl-4Gal~l-4Glc as cl 
chain, whereas F62 AS is limited 
to a lactosyl group  (9). Note that 
F62 wt and the two MS11 vari- 
ants  give  patterns  identical  to 
those published by Kerwood et al. (2). The LOS of variants 1-1, 2-1, and 
1-6 are clearly smaller than the F62 A1 parent, but similar to F62 A5. 
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Clones 
G residues 
Plasmid clone  lgtA  lgtC 
F62 dtl  10" 
Var I-1  17 
Var 2-1  11 
Var 1-6  17 
MS 11 Var A  12  8 
MS11 Var C  115  8 
Figure  3.  Sequence of PCR products from F62 variants. Genomic 
DNA of F62 dil  (lgtAA) and of variants 1-1 and 2-1 derived from this 
strain that no longer reacted with mAb 1-17-L1 was isolated. The ge- 
nomic area containing the poly-G region of lgtC was amplified  by PCR 
and the products sequenced as described in Materials and Methods. F62 
dil has 10 G residues, which is identical to the F62 wt (9). Variant 2-1 
clearly has 11 Gs. Variant 1-1 has a larger number of Gs that cannot be ac- 
curately estimated by the PCR technique. 
Each variant produced LOS  that was  smaller than that of 
the parent F62 A1 and was similar to the LOS ofF62 A5. 
We sequenced the poly-G region of the lgtC gene of the 
parent (F62 dll) and two of the variants by a PCR method; 
the  results are  shown in Fig.  3.  The sequence of F62 dil 
appears to have  10 Gs (identical to  F62 wild type), which 
puts lgtC in the "ON" configuration, that is, the remainder 
of the coding sequence is in frame (9).  Variant 2-1 appears 
to have one more G, which puts the gene in the  "OFF" 
configuration. Variant 1-1  has a larger number of Gs, but 
the exact number can not be determined. This is a short- 
coming of the PCR technique, which during amplification 
is also subject to slipped-strand mispairing and accumulates 
a population of products with different lengths of the poly- 
G  tract.  We  were  unable to  improve  the  fidelity of the 
PCR  reaction by modifying conditions or  by the  use  of 
other polymerases, including those with intact proofreading 
function. 
Since the F62 dil mutant contained an erythromycin re- 
sistance gene in proximity to  lgtC,  it was  simple to  clone 
this area of the genomic DNA and to sequence IgtC in the 
resulting plasmids.  The  results  are  listed  in  Table  1  and 
confirmed that F62 dil  had  10 Gs, variant 2-1  had  11  Gs, 
and showed that variant 1-1 had 17 Gs. The independently 
isolated variant 1-6 also had 17 Gs. Thus, all three variants 
selected for lack of reactivity with mAb  1-17-L1  showed 
shifts in the lgtC poly-G region that caused premature ter- 
mination of translation. We  used variant  1-6  to  perform 
colony blots and found that the reversion rate to reactivity 
with mAb 1-17-L1 was 3  ￿  10 -3. 
"10 G is in frame with the remainder of the coding frame of lgtC. 
11 G is in frame with the remainder of the coding frame of IgtA. 
We next wished to study the role of shifts in the poly-G 
region of lgtA.  We took advantage of a closely studied ex- 
ample of antigenic variation observed in a study in which 
volunteers were infected with strain MSlln& expressing a 
3,600 mol wt LOS phenotype (2).  Over the course of the 
infection, an increasing proportion of GC isolated from the 
volunteers were variants that produced a higher molecular 
weight LOS.  Two variants, B  and C,  predominated (16). 
Nuclear magnetic resonance and immunochemical analysis 
showed that the o~ chain of variant A  was a lactosyl group, 
whereas variant C  produced a complete pentasaccharide 0e 
chain. These variants were kindly provided by Dr. Herman 
Schneider, Walter Reed Army Institute of Research,  and 
Fig. 2  shows that the pattern of the LOS prepared in our 
laboratory  is  like  that  previously published  (2).  We  se- 
quenced the  IgtA  and the  lgtC regions and found that lgtC 
contained 8  Gs in both strains ("OFF").  The  lgtA  region 
changed from 12 in variant A  ("OFF") to  11  Gs in variant 
C  ("ON")  (see  Fig. 4). Thus, the loss of a single G  residue 
accounted  for  the  regained  ability to  synthesize  the  full 
LOS. To be certain of the number of G residues in the lgtA 
gene in these two variants, we also  cloned the relevant re- 
Figure  4.  Sequence of PCR 
products  from MSll  variants. 
Genomic DNA of MS11 variant 
A and variant C  were isolated, 
the  area containing the  poly-G 
region of the lgtA gene was am- 
plified by PCR, and the products 
were sequenced as described in 
Materials and  Methods. MS11 
variant  A  had  12  Gs,  which 
places lgtA out of frame and lim- 
its  the  ix  chain to  a  lactosyl 
group. Variant  C, an isolate from 
an infected volunteer, had 11 Gs 
and produced a complete LOS. 
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same answer (see Table 1). 
We were unable despite repeated colony blots to isolate 
from  variant  A  variants  producing  the  1-17-L1  epitope. 
Such variants should have been easy to detect because we 
were looking for gain in reactivity with the mAb. The fail- 
ure  to  isolate  antibody-reactive  variants  suggests  that  the 
run of 8 Gs in IgtC of that strain is not sufficiently long to 
expand or contract at a perceptible frequency. 
Discussion 
We  have  described  the  molecular  mechanism  for  the 
LOS phase variations that have been observed by previous 
investigators.  However,  the  selective  advantage to the  or- 
ganism of this genetic mechanism is unclear.  The  correla- 
tion of LOS structure with function is in its early stages.  A 
large  proportion  of human  bactericidal  antibodies  are  to 
LOS epitopes,  and its  structure influences the bacter~olytic 
effects  of human  serum  on  GC.  Some  GC  strains  when 
grown in vitro  are not killed by human serum  (Ser  R)  and 
are  common  among isolates  from patients  with  dissemi- 
nated  GC  infection  (17).  However,  most  GC  strains  are 
sensitive  (SerS). Many  Ser  s  strains  become  phenotypically 
Ser  p" when  incubated  in  the  presence  of cytidine  mono- 
phosphate  N-acetyl neuraminic  acid  (CMP-NANA).  GC 
possess a sialyl transferase that is capable of using exogenous 
CMP-NANA  to sialylate  its  LOS  (18).  Concentrations  of 
CMP-NANA in vivo are sufficient to support this reaction 
(19). The reaction depends on the LOS being a competent 
substrate.  It is well established that the lacto-N-neotetraose 
chain is the substrate for the sialylation leading to the Ser  R 
phenotype,  and  that  the  lactosyl o~  chain  is  not  modified 
(20). The resistance may be due to inability of antibodies to 
bind  to the  modified LOS,  but  there  also appears  to be  a 
general defect of effective complement deposition (21, 22). 
The ability of GC to adhere to epithelial cells  is a funda- 
mental attribute  of their virulence. Preeminent among GC 
adhesins are pill.  A  110-kD protein,  pilC,  present in small 
amounts  in  pill,  is  responsible  for adherence  to  epithelial 
cells.  The expression  of this protein is subject to high fre- 
quency  variation  by  a  frame-shift  mechanism  due  to  a 
stretch  of G  residues  early  in  the  coding frame  (10,  11). 
The  opacity  proteins  (opa)  are  also  important  adhesins. 
This  is  a  family  of 11  outer  membrane  proteins  that  are 
subject to high frequency variation by a frame-shift mecha- 
nism that involves a variable number of repeats of the pen- 
tameric  sequence  CTCTT  (23,  24).  Most of the  opa pro- 
teins promote adherence to polymorphonuclear phagocytes, 
and  sialylation  of the  LOS  strongly inhibits  this  opa  pro- 
tein-mediated  adherence  to  polymorphonuclear  phago- 
cytes (25).  One particular  opa protein  in strain MS11  not 
only promotes adherence to epithelial  cells,  but is essential 
for invasion of the cells  (26). van Putten (6) has shown that 
sialylation of LOS markedly inhibits epithelial cell invasion 
without  greatly altering adhesion.  His  studies  suggest  that 
in the mucosal infection, LOS that cannot be sialylated may 
be important for cell invasion.  On the other hand,  Griffiss 
et al.  (27)  reported that sialylation enhanced invasiveness in 
HEC-1-B cells. 
GC has clearly evolved in this locus alone a very elegant 
system to  shift  readily between  four different  LOS  struc- 
tures,  and at least one of these is subject to further modifi- 
cation  by  sialylation.  That  each  of the  various  o~  chain 
structures that the GC can produce is a mimic of a host car- 
bohydrate structure has raised the question of what the role 
of LOS may be in the  mucosal infection.  The host uses  a 
large  number  of ligand-binding  proteins  recognizing  the 
rich array of carbohydrate structures on glycolipids and gly- 
coproteins  for its  own homeostatic  purposes.  The  C-lec- 
tins, the S-lectins, and the sialoadhesins have binding speci- 
ficities  for structures  mimicked by LOS.  Thus,  it  is  likely 
that these  structures  on the  GC would also be recognized 
and may contribute  in important  ways to the  mucosal in- 
fection. 
This  ability  to shift  the  expression  among a  number  of 
different LOS structures is not peculiar to the GC, but ex- 
ists also in the meningococcus, where the genetics is likely 
to be very similar.  The laboratories  of Moxon and Hansen 
(28-30)  have  shown  that  this  also  occurs in  another  mu- 
cosal pathogen,  Haemophilus  influenzae,  where  at least  four 
genes are  subject  to phase variation.  In this  organism,  the 
mechanism is  also by slipped-strand  mispairing  due  to re- 
peated tetrameric sequences, which can be either CAAT or 
GCAA.  H.  influenzae  produces  chemically  similar  LOS, 
and  also  sialylates  its  LOS  (31).  The  existence  of this  ge- 
netic capability in H. influenzae and the pathogenic Neisseria 
ssp.  argues that organisms with phase-variable  LOS have a 
selective  advantage.  It strongly suggests  that  specific  LOS 
structures afford an advantage in one biological niche, but a 
disadvantage  in  another  host  environment,  and  that  these 
mucosal pathogens negotiate this dilemma by phase variation. 
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